Artificial intelligence is rapidly being adopted in healthcare, but studies have shown a ‘deskilling’ phenomenon. Routine exposure to medical artificial intelligence can pose deskilling risks for physicians. We discuss these risks and whether such systems violate the European Union Artificial Intelligence Act, the world’s first comprehensive regulatory framework on artificial intelligence.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Gerke, S. & Simon, D. A. How should we think about ambient listening and transcription technologies’ influences on EHR documentation and patient-clinician conversations? AMA J. Ethics 27, E787–E795 (2025).
Muehlematter, U. J., Daniore, P. & Vokinger, K. N. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015–20): a comparative analysis. Lancet Digit. Health 3, e195–e203 (2021).
Budzyń, K. et al. Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational study. Lancet Gastroenterol. Hepatol. 10, 896–903 (2025).
Soleymanjahi, S. et al. Artificial intelligence–assisted colonoscopy for polyp detection: a systematic review and meta-analysis. Ann. Intern. Med. 177, 1652–1663 (2024).
Corley, D. A. et al. Adenoma detection rate and risk of colorectal cancer and death. N. Eng. J. Med. 370, 1298–1306 (2014).
European Commission. AI Act. European Commission https://digital-strategy.ec.europa.eu/en/policies/regulatory-framework-ai (2025).
European Commission. Commission Guidelines on prohibited artificial intelligence practices established by Regulation (EU) 2024/1689 (AI Act). Communication from the Commission C(2025) 5052 final (European Commission, 2025).
Acknowledgements
This work was funded by the European Union (grant agreement no. 101057099). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Outside the submitted work, S.G. reports grants from the European Union (grant agreement no. 101057321). She is also a member of the Bayer Bioethics Council and a Research Fellow at the University of Copenhagen Faculty of Law, supported by a Novo Nordisk Foundation Grant for a scientifically independent International Collaborative Bioscience Innovation & Law Programme (Inter-CeBIL programme; grant no. NNF23SA0087056). C.H. has conflicts of interest with Odin Vision (consultation and device loan) and Olympus (device loan and speaking fees). Y.M. has conflicts of interest with Olympus (consultation, speaking fees and device loan) and Cybernet System (loyalty fees).
Rights and permissions
About this article
Cite this article
Gerke, S., Hassan, C. & Mori, Y. Human deskilling in medical artificial intelligence: prohibited or permissible under the EU Artificial Intelligence Act?. Nat Rev Gastroenterol Hepatol (2026). https://doi.org/10.1038/s41575-026-01210-y
Published:
Version of record:
DOI: https://doi.org/10.1038/s41575-026-01210-y